Delivery Order SPE2DR25D2014-SPE2DR26FZ95J
- Not listed
- The Defense Logistics Agency awarded a $1,162.96 delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 ml pens on December 8, 2025, with final completion scheduled for December 9, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitively awarded delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,635.36 to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 ml pens on November 17, 2025, with completion targeted for November 18, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's existing contract vehicle. The pharmaceutical product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication...
- The Defense Logistics Agency awarded a $2,180.40 delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 ml pens on December 8, 2025, with completion targeted for December 9, 2025. This is a firm fixed price, non-set-aside contract for pharmaceutical supply. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The...
- The Defense Logistics Agency awarded a $23,890.26 delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 mL pens on November 17, 2025, with an ultimate completion date of November 18, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used within military and federal healthcare systems to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Trulicity 3 mg/0.5 mL pens valued at $11,729.40 with a firm fixed-price structure. This delivery order represents a non-set-aside competitive award and is part of AmerisourceBergen's broader relationship with DLA as a critical pharmaceutical distributor. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, with an ultimate completion...
- The Defense Logistics Agency awarded a $1,588.34 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on December 5, 2025, with completion scheduled for December 8, 2025. This firm fixed price delivery order represents a non-set-aside competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $1,744.44 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 mL pens on December 11, 2025, with an ultimate completion date of December 12, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used in military and veteran healthcare...
- The Defense Logistics Agency awarded a $2,415.59 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pens on December 11, 2025, with completion targeted for December 12, 2025. This firm fixed-price, non-set-aside contract represents a routine pharmaceutical supply delivery executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 ml pens valued at $1,162.96, with a completion date of December 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used in military and federal healthcare systems to manage type 2 diabetes. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $7,043.40 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 mL pens on November 4, 2025, with completion expected by November 5, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. Trulicity is...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FZ95JDelivery Order
The Defense Logistics Agency awarded a $2,907.40 delivery order to AmerisourceBergen Drug Corp for Trulicity 3 mg/0.5 ml pens on December 11, 2025, with completion scheduled for December 12, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used within military and federal healthcare systems, consistent with AmerisourceBergen's role as a critical pharmaceutical distributor for defense medical supply chains. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at approximately $1 billion through December 2026. As a primary pharmaceutical vendor for the Defense Logistics Agency, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military healthcare programs globally. The company's contract portfolio demonstrates its capacity to fulfill federal procurement requirements across multiple therapeutic categories, positioning it as a key vendor for Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 12/10/25 |